Umoja Biopharma
A Head of Drug Product Development at Umoja Biopharma leads internal and external drug product manufacturing processes for lentiviral vectors, including formulation development, fill-finish, and technology transfer activities for early and late-stage programs. The role also involves leading a facility capital project to upgrade fill-finish manufacturing capabilities.
Headquarters
Seattle, Washington, United States
Company Size
51-200 employees
Founded
2019
Umoja Biopharma is a biotechnology company advancing in vivo CAR T cell therapies for cancer using its VivoVec platform to generate CAR T cells directly inside a patient’s body. This approach aims to provide immediate drug availability, bypassing the weeks-to-months manufacturing timeline of traditional ex vivo CAR T therapies, and the company maintains in-house manufacturing to scale production and support its clinical pipeline.
Nona Biosciences Announces Expansion of Collaboration with Umoja Biopharma to Advance In Vivo CAR-T Cell Therapies
Nov 5, 2025
Umoja Biopharma Named One of 2025’s Most Promising Biotech Companies by Endpoints News and Fierce Biotech
Sep 23, 2025
Umoja secures $100M series C to bring more CAR-Ts into the clinic
Jan 14, 2025
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Umoja Biopharma.
12% above the average for this role
Seattle immunotherapy startup Umoja Biopharma raises $100M
Jan 14, 2025
Principal Scientist Drug Product Development
AstraZeneca
Drug Product Development Scientist - Viral Vector
AstraZeneca
Drug Product Development Scientist Viral Vector Gaithersburg Maryland United States Of America
AstraZeneca
Senior Scientist Drug Product
AstraZeneca
Director, External Manufacturing - Viral Vector Technical Lead
AstraZeneca
Principal Scientist Drug Product Development
AstraZeneca